Bone Healing

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

  • FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. 

    , , ,

    Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…

    Read More...

  • Prof. Luke O’Neill showcasing our partner ZOAN Biomed

    ,

      Zoan G03, a product created by our partner Zoan Biomed was showcased yesterday evening on new RTÉ show ‘Future Island’. ZoanG03 is a bioactive bone healing device. The corals’ Natural Assembly Process ensures every surface, every pore and every mineral contribute to building a living scaffold. Superior bioactivity stimulates speedy and complete acceptance by…

    Read More...

Connect with us on LinkedIn
Search News Items
Categories